Rakuten Medical, Inc.
Wednesday, June 05, 2024
Oncology
Company Presentation Theater 1
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies based on its Alluminox™ technology platform, which has been shown to induce rapid and selective cell killing and tumor necrosis. Our lead product ASP-1929 is conditionally approved and commercially available in Japan and is currently being evaluated in a global phase 3 clinical study. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives.
Company Website:
https://rakuten-med.com/us/
Lead Product in Development:
ASP-1929
Company HQ City
San Diego
Company HQ State
California
Company HQ Country
United States
CEO/Top Company Official
Hiroshi "Mickey"Mikitani
Development Phase of Primary Product
Phase III
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())